Characterizing human respiratory syncytial virus among children admitted with acute respiratory tract infections from 2019 to 2022

Abstract

AbstractRespiratory syncytial virus is a major causative agent of lower respiratory tract infection in children, especially infants with substantial morbidity and mortality implications. The virus undergoes continuous evolution documented by accumulation of mutations in the glycoprotein gene necessitating vigilant surveillance to provide essential data to epidemiologists and researchers involved in development of vaccines. This study was aimed to perform molecular characterization of respiratory syncytial virus (RSV) among children ≤ 5 years admitted in hospital. In the current study we observed RSV‐A (2019 (n = 95) and 2021 (n = 61) seasons) and RSV‐B (2022 season (n = 68)). Phylogenetic analysis revealed all RSV‐A strains (n = 47) to be GA.2.3.5 and RSV‐B (n = 22) were classified as GB.5.0.5a. Selection pressure analysis identified one positive (P274L/V) and one negative site (P230T) in RSV–A, while in RSV‐B there was only one negatively selected site (S295). This study spanning over three seasons contributes to RSV evolutionary dynamics in India emphasizing the importance of on‐going surveillance to inform effective public health strategies and vaccine development efforts.